
Australian Journal of Chemistry p. 391 - 395 (2013)
Update date:2022-08-05
Topics:
Froschauer, Carmen
Salchner, Robert
Laus, Gerhard
Weber, Hedda K.
Tessadri, Richard
Griesser, Ulrich
Wurst, Klaus
Kahlenberg, Volker
Schottenberger, Herwig
A new and convenient synthetic pathway to 1,3-di(alkoxy)imidazolium bis(trifluoromethylsulfonyl)amides and novel 1,3-di(alkoxy)imidazolium tetrachloroferrates was developed. As an intermediate isolation step of the respective hexafluorophosphates was required in previously reported preparations, they suffered from low overall yields and additional expense. The use of FeCl3/HCl resulted in substantially improved yields and allows one-pot preparations with good scalability. Results of single-crystal X-ray structure determination of the new tetrachloroferrate salts are discussed.
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Contact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Contact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
Hebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Contact:86-511-85210668 0511-85210668, 85210818, 85210898
Address:Yihai Garden E-902,NO.99 Daxi RD., Zhenjiang Jiiangsu ,China
Doi:10.1002/ejoc.202001111
(2020)Doi:10.1039/c000862a
(2010)Doi:10.3390/molecules15085104
(2010)Doi:10.1055/s-0029-1218702
(2010)Doi:10.1002/ejoc.201000220
(2010)Doi:10.1016/j.bmcl.2010.04.039
(2010)